Nephros (NEPH) Operating Leases (2019 - 2026)

Nephros' Operating Leases history runs 8 years deep, the most recent figure standing at $566000.0 for Q1 2026.

• On a quarterly basis, Operating Leases fell 41.59% year-over-year to $566000.0 in Q1 2026; TTM through Mar 2026 was $566000.0, a 41.59% decrease from a year earlier, with the FY2025 full-year figure at $672000.0, down 36.78% from the prior year.
• Operating Leases declined to $566000.0 in Q1 2026 per NEPH's latest filing, from $672000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $1.4 million in Q4 2023 and bottomed at $201000.0 in Q3 2022.
• The 5-year median for Operating Leases is $705000.0 (2022), against an average of $777941.2.
• Across the five-year window, Operating Leases surged 146.06% in 2024 and sank 41.59% in 2026, its largest moves.
• Year by year, Operating Leases stood at $705000.0 in 2022, then soared by 97.16% to $1.4 million in 2023, then dropped by 23.53% to $1.1 million in 2024, then tumbled by 36.78% to $672000.0 in 2025, then decreased by 15.77% to $566000.0 in 2026.
• Per Business Quant, the three latest NEPH Operating Leases figures stand at $566000.0 (Q1 2026), $672000.0 (Q4 2025), and $774000.0 (Q3 2025).